| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |